Chief Medical Officer Archives | Be Korea-savvy
Nanobiotix Appoints New Chief Medical Officer as the Company Evolves After Achievement of European Market Approval

Nanobiotix Appoints New Chief Medical Officer as the Company Evolves After Achievement of European Market Approval

Paris, France and Cambridge, Massachusetts, USA, Jun. 4 (Korea Bizwire) – NANOBIOTIX (Euronext: NANO – ISIN: FR0011341205), a clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced it has appointed Edwina Baskin-Bey, M.D. as its new CMO. Dr. Baskin-Bey brings over 18 years of oncology clinical development and basic science experience [...]

Ascension Healthcare plc: Appointment of Dr. Gavin Ling as Chief Medical Officer

Ascension Healthcare plc: Appointment of Dr. Gavin Ling as Chief Medical Officer

LONDON, Jan. 7 (Korea Bizwire) – Ascension Healthcare plc (“Ascension” or the “Company”), a clinical-stage biopharmaceutical company focused on developing and commercialising innovative therapies for haemophilia and osteoarthritis is pleased to announce the appointment of Dr Gavin Ling as Chief Medical Officer. Biresh Roy, Chief Executive Officer of Ascension said: “We are delighted to have [...]

Quanta Appoints Dr. Paul Komenda as New Chief Medical Officer

Quanta Appoints Dr. Paul Komenda as New Chief Medical Officer

Alcester, Warwickshire, UK, Jan. 4 (Korea Bizwire) - Quanta Dialysis Technologies Ltd (“Quanta” or the “Company”), a medical device company providing innovative haemodialysis solutions for clinic and home settings, today announces that the Company has appointed Dr. Paul Komenda as Chief Medical Officer. Dr. Komenda, Associate Professor of Medicine at the University of Manitoba, is a [...]

Druggability Technologies USA Announces Appointment of John E. Friend II, M.D. as Chief Medical Officer

Druggability Technologies USA Announces Appointment of John E. Friend II, M.D. as Chief Medical Officer

NEW YORK, Dec. 6 (Korea Bizwire) — Druggability Technologies USA today announced that Dr.  John E. Friend II has been named as Chief Medical Officer. Druggability Technologies USA has been engaged by Druggability Technologies Holding (DRGT) to assist with the clinical development of all human trials for DRGT. DRGT is a specialty pharmaceutical company that [...]

Neuralstem Strengthens Executive Leadership Team with Appointment of Dr. David Recker as Chief Medical Officer

Neuralstem Strengthens Executive Leadership Team with Appointment of Dr. David Recker as Chief Medical Officer

GERMANTOWN, Md., Nov. 8 (Korea Bizwire) — Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company developing novel treatments for nervous system diseases, today announced the appointment of David Recker, MD, FACR, FACP, as Chief Medical Officer. “Given his extensive experience in the biopharma industry, Dr. Recker brings to Neuralstem an expertise that will be critical to the [...]